Allergy and Immunology · Knoxville, TN
NPI
1831355833
Since 2008
Specialty
Allergy and Immunology
Code 207K00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
801 N Weisgarber Rd, Suite 200
Knoxville, TN, 37909
Phone (865) 584-8588
Groups this clinician bills Medicare through
Medicare paid, 2024
$837K
50,410 services
Medicare patients, 2024
529
Average age 72
Drug cost, 2024
$1.7M
1,713 prescriptions
Company payments, 2025
$2,245
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jeremiah N Bivins was code 95165 (treatment - miscellaneous), 7,810 times for 164 patients. In total Jeremiah N Bivins billed 50,410 services in 32 codes, and Medicare paid $837K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-02-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 95165 Treatment - Miscellaneous | Office | 7,810 | 164 | $9.80 | $77K |
| 95004 Test - Miscellaneous | Office | 7,282 | 99 | $2.45 | $18K |
| 95117 Treatment - Miscellaneous | Office | 2,514 | 267 | $7.70 | $19K |
| J2357 Injection, omalizumab, 5 mg | Office | 2,295 | 13 | $29.61 | $68K |
| J0517 Injection, benralizumab, 1 mg | Office | 1,860 | 27 | $130.84 | $243K |
| 95024 Test - Miscellaneous | Office | 1,401 | 89 | $5.45 | $7,637 |
| 95044 Test - Miscellaneous | Office | 488 | 23 | $3.50 | $1,709 |
| 95115 Treatment - Miscellaneous | Office | 321 | 38 | $6.51 | $2,088 |
| 96372 Injection Administration | Office | 265 | 66 | $10.04 | $2,660 |
| 99213 Office E&M - Established | Office | 162 | 141 | $58.11 | $9,414 |
| J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | Office | 114 | 38 | $0.04 | $4.19 |
| 94010 Pulmonary Function Testing | Office | 81 | 76 | $17.91 | $1,451 |
| 99204 Office E&M - New | Office | 66 | 66 | $107.01 | $7,063 |
| 99203 Office E&M - New | Office | 59 | 59 | $65.18 | $3,846 |
| 94060 Pulmonary Function Testing | Office | 42 | 42 | $26.30 | $1,105 |
By year: 2022 $518K for 32,571 services; 2023 $645K for 41,498 services; 2024 $837K for 50,410 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jeremiah N Bivins prescribed most often to Medicare patients was Ipratropium Bromide, with 199 prescriptions and refills. In total Jeremiah N Bivins wrote 1,713 Medicare prescriptions that cost $1.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ipratropium Bromide Generic | 199 | 262 | 80 | $6,129 |
| Fluticasone Propionate Generic | 174 | 257 | 50 | $2,507 |
| Montelukast Sodium Generic | 159 | 285 | 36 | $1,431 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 130 | 160 | 60 | $3,177 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 66 | 74 | 16 | $48K |
| Levocetirizine Dihydrochloride Generic | 60 | 118 | 16 | $491 |
| Dupixent Syringe Dupilumab | 59 | 59 | Under 11 | $220K |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 58 | 84 | 15 | $53K |
| Symbicort Budesonide/Formoterol Fumarate | 57 | 76 | 17 | $17K |
| Xolair Omalizumab | 57 | 59 | Under 11 | $154K |
| Azelastine Hcl Generic | 56 | 111 | 25 | $1,393 |
| Breo Ellipta Fluticasone/Vilanterol | 51 | 57 | Under 11 | $22K |
| Epinephrine Generic | 44 | 49 | 41 | $9,422 |
| Fasenra Benralizumab | 44 | 76 | 14 | $240K |
| Arnuity Ellipta Fluticasone Furoate | 38 | 46 | Under 11 | $10K |
Brand drugs: 719 claims; generic drugs: 994 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jeremiah N Bivins $2,245 ($2,245 in general payments such as food, travel and fees) from 18 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $402.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 20 | $402 |
| Genzyme Corporation SNY | 11 | $312 |
| Regeneron Healthcare Solutions, Inc. REGN | 7 | $195 |
| Novartis Pharmaceuticals Corporation NVS | 7 | $192 |
| CSL Behring CSL.AX | 8 | $191 |
| GlaxoSmithKline, LLC. GSK | 11 | $186 |
| BioCryst US Sales Co., LLC | 6 | $185 |
| Pfizer Inc. PFE | 4 | $107 |
| ARS Pharmaceuticals Operations, Inc. SPRY | 4 | $89.52 |
| Genentech USA, Inc. ROG.SW | 3 | $76.31 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.